MEX3A and liver cancer: Univariate and Multivariate Cox analysis suggested that MEX3A (HR = 2.19, 95% CI [1.54–3.12], p < 0.0001) was an independent risk factor to evaluate the RFS for liver cancer along with T stage (p < 0.0001) and residual tumor status (p = 0.024; Table 4).